首页|瑞芬太尼诱发痛觉过敏机制及防治策略的研究新进展

瑞芬太尼诱发痛觉过敏机制及防治策略的研究新进展

扫码查看
瑞芬太尼具有起效快、半衰期短、长时间输注无蓄积等优点,是临床工作中广泛应用的阿片类药物.瑞芬太尼除了在术中发挥镇痛作用,还可导致术后机体对疼痛敏感性增高,即瑞芬太尼诱发痛觉过敏(remifentanil-induced hyperalgesia,RIH),严重影响病人术后恢复及生活质量.RIH的发生发展机制错综复杂,涉及受体功能失调、离子通道改变以及神经炎症等诸多因素.本文就RIH发生机制及防治策略的研究进展进行综述,旨在为今后分子机制研究及临床诊疗策略提供理论参考.
Recent progress in research on mechanisms and preventive strategies for remifentanil-induced hyperalgesia
Remifentanil is an opioid medicine,which widely used in clinical practice due to its rapid onset,short half-life,and lack of accumulation with prolonged infusion.Apart from its analgesic effect during surgery,remifentanil can also increase postoperative pain sensitivity,which is known as remifentanil-induced hyperalgesia(RIH).RIH has an significant affect on patients'postoperative recovery and quality of life.The mechanisms of the development of RIH are complex and intricate.This article reviews recent progress in the understanding of the mechanisms and preventive strategies for RIH,aiming to provide theoretical references for future molecular mechanism research and clinical treatment strategies.

remifentanilhyperalgesiamechanismspreventive strategies

张瑾瑾、张达颖

展开 >

南昌大学第一附属医院疼痛科,南昌 330006

江西省卫生健康委员会神经性疼痛重点实验室,南昌 330006

瑞芬太尼 痛觉过敏 机制 防治策略

国家重点研发计划主动健康和人口老龄化科技应对重点专项江西省研究生创新专项基金

2022YFC3602202YC2022-B061

2024

中国疼痛医学杂志
北京大学,中华医学会疼痛学分会

中国疼痛医学杂志

CSTPCD北大核心
影响因子:1.457
ISSN:1006-9852
年,卷(期):2024.30(9)